FDA Grants Breakthrough Designation to VT Ablation System
The pulsed field ablation technology for ventricular tachycardia has been granted FDA Breakthrough Device Designation and accepted into the TAP pilot program.
The pulsed field ablation technology for ventricular tachycardia has been granted FDA Breakthrough Device Designation and accepted into the TAP pilot program.